AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (two doses in adults)
Number of subjects: 430
Study 36085612 — intervention group
Group type: EXPERIMENTAL
Intervention: High group (engaged in psychological processing of CDT)
Number of subjects: 0
Study 36085612 — intervention group
Group type: EXPERIMENTAL
Intervention: Low group (possibly ignoring the appearance of CDT)
Number of subjects: 0
Study 32696905 — intervention group
Group type: COMPARATOR
Intervention: Etching time of 15 seconds (recommended by manufacturer)
Number of subjects: 62
Study 32696905 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching time of 7 seconds (reduced)
Number of subjects: 62
Study 34287975 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional RF treatment with 1.0‐mm long × 0.15‐mm diameter ultrathin electrode tips
Number of subjects: 9
Study 32964771 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive Function Training (EFT)
Number of subjects: 96
Study 32964771 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (Control)
Number of subjects: 96
Study 32234355 — intervention group
Group type: EXPERIMENTAL
Intervention: PowerPoint-style educational intervention with grade-conscious written material and visual graphics
Number of subjects: 52
Study 32234355 — intervention group
Group type: EXPERIMENTAL
Intervention: PowerPoint-style educational intervention
Number of subjects: 52
Study 32234355 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 34280545 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 0
Study 34280545 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 0
Study 33865382 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support intervention consisting of the electronic Social Network Assessment Program and Caregiver Navigation (8-week duration)
Number of subjects: 0
Study 33865382 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 32680773 — intervention group
Group type: EXPERIMENTAL
Intervention: MRKAd5/HIV‐1
Number of subjects: 0
Study 32680773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32844454 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanolin-containing test creams applied twice daily for 4 weeks on arms with irritant dermatitis
Number of subjects: 26
Study 32844454 — intervention group
Group type: COMPARATOR
Intervention: Lanolin-free cream base applied twice daily for 4 weeks on arms with irritant dermatitis
Number of subjects: 26
Study 35276700 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exposure treatment (GET)
Number of subjects: 27
Study 33564980 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported 3-month anal intercourse occurrence
Number of subjects: 407
Study 33564980 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported frequency of anal intercourse
Number of subjects: 407
Study 33564980 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds of discordance associated with dyadic employment and CCS differences
Number of subjects: 407
Study 33564980 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean relative difference in frequency reports among discordant couples
Number of subjects: 407
Study 33564980 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative differences between partners' reported AI frequencies
Number of subjects: 407
Study 36379691 — intervention group
Group type: EXPERIMENTAL
Intervention: Online video intervention guided by the extended theory of planned behavior
Number of subjects: 692
Study 36379691 — intervention group
Group type: COMPARATOR
Intervention: Regular short reminder messages (Control)
Number of subjects: 692
Study 34051122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol (50 mg twice daily)
Number of subjects: 21
Study 34051122 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (10 mg twice daily)
Number of subjects: 21
Study 35643018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (mobile applications, smartwatches, smartphone-based short text messages, and telephone counselling)
Number of subjects: 43
Study 35643018 — intervention group
Group type: COMPARATOR
Intervention: Short text messages and telephone counselling (control group)
Number of subjects: 43
Study 34053490 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 28
Study 34053490 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 28
Study 36087564 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach bias modification (ApBM)
Number of subjects: 300
Study 36087564 — intervention group
Group type: COMPARATOR
Intervention: Sham training (Control)
Number of subjects: 300
Study 33444780 — intervention group
Group type: EXPERIMENTAL
Intervention: BASE programme (remotely supervised exercise programme)
Number of subjects: 72
Study 33444780 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72
Study 33444780 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised adherence treatment (post-programme)
Number of subjects: 72
Study 33444780 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual adherence (post-programme)
Number of subjects: 72
Study 35993480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 35993480 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 32
Study 32538115 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (group II)
Number of subjects: 60
Study 32538115 — intervention group
Group type: COMPARATOR
Intervention: Plain old balloon (group I)
Number of subjects: 60
Study 36251383 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (6 mg·kg ‐1 body weight)
Number of subjects: 13
Study 34037271 — intervention group
Group type: EXPERIMENTAL
Intervention: RO7062931 at 3.0 mg/kg every week (QW)
Number of subjects: 59
Study 34037271 — intervention group
Group type: EXPERIMENTAL
Intervention: RO7062931 at 0.5, 1.5, or 3.0 mg/kg every month for a total of 2 doses
Number of subjects: 59
Study 34037271 — intervention group
Group type: EXPERIMENTAL
Intervention: RO7062931 at 3.0 mg/kg every 2 weeks, 3.0 mg/kg every week (QW), or 4.0 mg/kg QW
Number of subjects: 59
Study 34037271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 32327444 — intervention group
Group type: EXPERIMENTAL
Intervention: High-GI test meal (TM) consumed at dinner
Number of subjects: 34
Study 32327444 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-GI test meal (TM) consumed at dinner
Number of subjects: 34
Study 32327444 — intervention group
Group type: EXPERIMENTAL
Intervention: High-GI test meal (TM)
Number of subjects: 34
Study 32327444 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-GI test meal (TM)
Number of subjects: 34
Study 32327444 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meals (TM) consumed at dinner
Number of subjects: 34
Study 36027721 — intervention group
Group type: EXPERIMENTAL
Intervention: idursulfase-IT 10 mg
Number of subjects: 49
Study 36027721 — intervention group
Group type: EXPERIMENTAL
Intervention: idursulfase-IT
Number of subjects: 49
Study 36027721 — intervention group
Group type: COMPARATOR
Intervention: no idursulfase-IT
Number of subjects: 49
Study 33811746 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line platinum-based chemotherapy (carboplatin/paclitaxel)
Number of subjects: 39
Study 33811746 — intervention group
Group type: EXPERIMENTAL
Intervention: Good responders (GR)
Number of subjects: 39
Study 33811746 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor responders (PR)
Number of subjects: 39
Study 33811746 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression analysis by NanoString
Number of subjects: 39
Study 33811746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor immune cell infiltration
Number of subjects: 39
Study 33288404 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% Mannitol
Number of subjects: 40
Study 33288404 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 40
Study 35971156 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural economics-informed SMS and voice reminder messages
Number of subjects: 0
Study 35971156 — intervention group
Group type: COMPARATOR
Intervention: Standard SMS message
Number of subjects: 0
Study 33551138 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne‐particle abrasion (Tbc)
Number of subjects: 120
Study 33551138 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne‐particle abrasion + plasma treated (Tbc_NTP)
Number of subjects: 120
Study 33551138 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 120
Study 33551138 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthermal plasma (NTP) treated
Number of subjects: 120
Study 33551138 — intervention group
Group type: EXPERIMENTAL
Intervention: Abraded with a coarse‐grit diamond rotary instrument (Ab)
Number of subjects: 120
Study 33551138 — intervention group
Group type: EXPERIMENTAL
Intervention: Abraded + plasma treated (Ab_NTP)
Number of subjects: 120
Study 32150263 — intervention group
Group type: EXPERIMENTAL
Intervention: D0 rituximab infusion (500 mg)
Number of subjects: 161
Study 32150263 — intervention group
Group type: COMPARATOR
Intervention: D0+D14 rituximab infusion (500 mg)
Number of subjects: 161
Study 35144885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole, twice daily for 10 days postoperatively
Number of subjects: 93
Study 35144885 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 10 days postoperatively
Number of subjects: 93
Study 35144885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole
Number of subjects: 93
Study 35144885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34113593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month mixed exercise training program supervised at the hospital, followed by 2 months in a community-based relay in a health-sport structure, combined with therapeutic patient education sessions
Number of subjects: 330
Study 34113593 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic patient education sessions
Number of subjects: 330
Study 36378832 — intervention group
Group type: EXPERIMENTAL
Intervention: Group hypnosis
Number of subjects: 64
Study 36198449 — intervention group
Group type: EXPERIMENTAL
Intervention: aLiFE or eLiFE (six-month trainer-supported)
Number of subjects: 120
Study 36198449 — intervention group
Group type: COMPARATOR
Intervention: Control group (written PA advice)
Number of subjects: 120
Study 33002436 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) plus trastuzumab emtansine (3.6 mg/kg)
Number of subjects: 202
Study 33002436 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus trastuzumab emtansine (3.6 mg/kg)
Number of subjects: 202
Study 34658725 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol
Number of subjects: 164
Study 34658725 — intervention group
Group type: COMPARATOR
Intervention: Intermittent bolus application of propofol
Number of subjects: 164
Study 37507795 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma3 cephalomedullary nailing
Number of subjects: 0
Study 37507795 — intervention group
Group type: COMPARATOR
Intervention: IT cephalomedullary nailing
Number of subjects: 0
Study 33961058 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive fluid management
Number of subjects: 100
Study 33961058 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 32320373 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic prediction using trait-related markers
Number of subjects: 509
Study 32320373 — intervention group
Group type: EXPERIMENTAL
Intervention: GWAS identified SNPs associated with FER resistance
Number of subjects: 509
Study 32320373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulked sample analysis (BSA)
Number of subjects: 509
Study 32320373 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear rot evaluation using artificial inoculation
Number of subjects: 509
Study 32810553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 189
Study 32810553 — intervention group
Group type: COMPARATOR
Intervention: Regorafenib
Number of subjects: 189
Study 32810553 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC)/placebo
Number of subjects: 189
Study 32540410 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 6430
Study 36149321 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole buccal tablets (MBT) plus placebo
Number of subjects: 431
Study 36149321 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole capsules plus placebo
Number of subjects: 431
Study 35840067 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic suspension allograft (ASA)
Number of subjects: 95
Study 33962356 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world efficacy data from DAMMED
Number of subjects: 4156
Study 33962356 — intervention group
Group type: COMPARATOR
Intervention: Published randomized clinical trial data
Number of subjects: 4156
Study 32989067 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity organizational change intervention with in-person education and remote support from peer mentors and a physician informaticist.
Number of subjects: 32
Study 32989067 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity organizational change intervention.
Number of subjects: 32
Study 32989067 — intervention group
Group type: COMPARATOR
Intervention: Control practices (no specific intervention mentioned).
Number of subjects: 32
Study 35832800 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic low-temperature thermoplastic plate fixation and routine rehabilitation (Group B)
Number of subjects: 50
Study 35832800 — intervention group
Group type: COMPARATOR
Intervention: Plaster fixation and routine rehabilitation (Group A)
Number of subjects: 50
Study 34156335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training plus usual-care maintenance haemodialysis
Number of subjects: 379
Study 34156335 — intervention group
Group type: COMPARATOR
Intervention: Usual-care maintenance haemodialysis
Number of subjects: 379
Study 34156335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training
Number of subjects: 379
Study 36308858 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood exposure
Number of subjects: 40
Study 36308858 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood exposure
Number of subjects: 40
Study 33284166 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplantation group
Number of subjects: 10646
Study 33284166 — intervention group
Group type: COMPARATOR
Intervention: Awaiting transplantation group
Number of subjects: 10646
Study 32118694 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental resilience measured using the Connor-Davidson Resilience Scale at the time of consent
Number of subjects: 232
Study 32118694 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Reported Outcome Measurement Information System Short Forms 8a for Depression and Anxiety
Number of subjects: 232
Study 32118694 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of Event Scale-Revised for posttraumatic stress
Number of subjects: 232
Study 32118694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Family Satisfaction-ICU 24 for parental satisfaction
Number of subjects: 232
Study 35051670 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep study screening with autoregulated positive airway therapy
Number of subjects: 193
Study 35051670 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard obstetrical care)
Number of subjects: 193
Study 33492018 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based care group (ART Co-op)
Number of subjects: 0
Study 33492018 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (clinic-based care)
Number of subjects: 0
Study 36752451 — intervention group
Group type: EXPERIMENTAL
Intervention: RF wire
Number of subjects: 75
Study 36752451 — intervention group
Group type: COMPARATOR
Intervention: RF needle
Number of subjects: 75
Study 33524283 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography screening
Number of subjects: 0
Study 33524283 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35188812 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic technique
Number of subjects: 18
Study 35188812 — intervention group
Group type: COMPARATOR
Intervention: Docking technique
Number of subjects: 18
Study 32889556 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-tunnel (ST) MPFL reconstruction
Number of subjects: 80
Study 32889556 — intervention group
Group type: COMPARATOR
Intervention: Double-tunnel (DT) MPFL reconstruction
Number of subjects: 80
Study 32543155 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback combined with task-oriented training
Number of subjects: 66
Study 34520419 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group with access to an immersive commercially available VR learning module
Number of subjects: 22
Study 34520419 — intervention group
Group type: COMPARATOR
Intervention: Guide group with access to manufacturer's technique guide and surgical video
Number of subjects: 22
Study 34520419 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 22
Study 34520419 — intervention group
Group type: COMPARATOR
Intervention: Guide group
Number of subjects: 22
Study 35406010 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (1200 IU/day) + DHA (500 mg)
Number of subjects: 73
Study 35406010 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D (1200 IU/day) + wheat germ oil
Number of subjects: 73
Study 34620658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-800CW (4, 5, 10 or 25 mg)
Number of subjects: 15
Study 32202318 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 97
Study 36151971 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention
Number of subjects: 53
Study 36151971 — intervention group
Group type: COMPARATOR
Intervention: Usual control
Number of subjects: 53
Study 33619202 — intervention group
Group type: COMPARATOR
Intervention: Immediate antibiotics alone (n=15)
Number of subjects: 67
Study 33619202 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antibiotics and immediate cranberry capsules for up to 7 days (n=15)
Number of subjects: 67
Study 33619202 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cranberry capsules and delayed antibiotics for self-initiation in case of non-improvement or worsening of symptoms (n=16)
Number of subjects: 67
Study 34140405 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrageenan gel
Number of subjects: 255
Study 34140405 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 255
Study 34564057 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate for 4 weeks
Number of subjects: 12
Study 34564057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33177355 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Complete Mesocolic Excision (CME)
Number of subjects: 0
Study 33177355 — intervention group
Group type: COMPARATOR
Intervention: Conventional right-sided colonic resection (NCME)
Number of subjects: 0
Study 32116309 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Functional Skills Training (CFST)
Number of subjects: 95
Study 32116309 — intervention group
Group type: COMPARATOR
Intervention: Combined Cognitive Training (CCT) plus CFST
Number of subjects: 95
Study 35140146 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention (primary care pharmacist, family doctor, nurse) conducting multidimensional reviews and clinical interviews
Number of subjects: 0
Study 35140146 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical practice (control group)
Number of subjects: 0
Study 34611435 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 300
Study 34611435 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural anaesthesia (TEA)
Number of subjects: 300
Study 35413787 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80
Study 35413787 — intervention group
Group type: COMPARATOR
Intervention: LMA Protector
Number of subjects: 80
Study 34291590 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (3–6 mg twice a day)
Number of subjects: 91
Study 34291590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 34291590 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 91
Study 35584331 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% NaOCl solution (deproteinization)
Number of subjects: 30
Study 35584331 — intervention group
Group type: COMPARATOR
Intervention: Control group (acid etching with 37% phosphoric acid + placebo solution + Adper Single Bond 2/3M Oral Care + Filtek Z350/3M Oral Care)
Number of subjects: 30
Study 33611826 — intervention group
Group type: EXPERIMENTAL
Intervention: wet silver-containing dressings (n = 28)
Number of subjects: 58
Study 33611826 — intervention group
Group type: COMPARATOR
Intervention: wet to dry povidone-iodine dressings (n = 30)
Number of subjects: 58
Study 35220503 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (FOLFOX or CAPOX)
Number of subjects: 0
Study 35220503 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 0
Study 35641662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone (2403 mg/day)
Number of subjects: 22
Study 35641662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 22
Study 32603714 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening long‐acting bronchodilation (aclidinium bromide/formoterol fumarate dihydrate: 400/12 μg)
Number of subjects: 20
Study 32603714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32603714 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening long‐acting bronchodilator (aclidinium bromide/formoterol fumarate dihydrate: 400/12 μg)
Number of subjects: 20